Join us for
this special Event
Tumor Acidity: A new approach to targeting breast and other tumors
Tuesday, May 2, 2017
Noon - 1:30pm
Noble Conference Center
Speaker: Donald Max Engelman, PhD
Higgins Professor of Molecular Biophysics and Biochemistry, Yale University
Tumors are acidic, and the more aggressive a tumor is, the more acidic it is. Dr. Engelman and his team have developed new ways to take advantage of tumor acidity as a target for diagnosis and therapy. Despite advances in early detection and understanding of the molecular bases of breast cancer biology, approximately 30% of all patients with early-stage breast cancer have recurrent disease, which is metastatic in most cases. Acidity may be a better target than markers used in other approaches that often fail through the emergence of resistant tumors. Dr. Engelman, accompanied by John Deacon, PhD, associate research scientist, will explain tumor heterogeneity, acidity, and their new approaches.
To register, call 203-863-4277 or 888-305-8253. Or register online at GreenwichHospital.org/Events. FREE.
An optional boxed lunch is available for $10. Please order by April 24.
Visitor Parking at Greenwich Hospital is very limited and carpooling is encouraged.
Sponsored by the
Greenwich Hospital Women's Health Initiative
Advisory Board: Shelley H. Behrman, Chairman; Missy Baschkin; Jane M. Batkin; Karen Brown; Susan H. Brown; Serena Flaherty; Pamela M. Goergen; Mary A. Jacobson; Anne Juge; Louise Kovacs; Shelley Tretter Lynch; Susan Z. Mandel; Barbara B. Miller; Barbara Netter; Mini Nunna; Sharon Phillips; Carol M. Santora; Carol Swift; Katherine Vadasdi, MD